INMUNE BIO INC. Temporary Equity, Aggregate Amount of Redemption Requirement
INMUNE BIO INC. (INMB) had Temporary Equity, Aggregate Amount of Redemption Requirement of $799.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-01.
Financial Statements › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement · last filed 2024-10-31
- 2024-06-30: Temporary Equity, Aggregate Amount of Redemption Requirement $799.00K.
- 2024-03-31: Temporary Equity, Aggregate Amount of Redemption Requirement $799.00K.
- 2023-12-31: Temporary Equity, Aggregate Amount of Redemption Requirement $799.00K.
| Period end | Temporary Equity, Aggregate Amount of Redemption Requirement |
|---|---|
| 2024-06-30 | $799.00K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $799.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $799.00K 10-Q · filed 2024-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |